Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Cipher Pharmaceuticals Inc T.CPH

Alternate Symbol(s):  CPHRF

Cipher Pharmaceuticals Inc. is a Canada-based specialty pharmaceutical company with a diversified portfolio of commercial and early to late-stage products. The Company acquires products that fulfill unmet medical needs, manages the required clinical development and regulatory approval process, and markets those products either directly in Canada or indirectly through partners in Canada, the United States and South America. Its Dermatology products include Actikerall, Epuris, Ozanex and Vaniqa. Its Hospital Acute Care products include Aggrastat and Brinavess. Its Out-Licensed products include Absorica, ConZip and Lipofen. The Company is also focused on building a portfolio of prescription medicines that serve unmet medical needs. The Company's product pipeline development programs including MOB-015, DTR-001, and CF-101. The Company's subsidiaries include Cipher US Holdings Inc., Cipher US Holdco LLC, and Cipher Pharmaceuticals US LLC.


TSX:CPH - Post by User

Post by stockfyon Nov 14, 2022 5:16am
750 Views
Post# 35095811

CPH: Outperformer, Give Credit When Credit Is Due

CPH: Outperformer, Give Credit When Credit Is Due
I just want to give credit where credit is due. I bought CPH thanks to Value Digger, a veteran fund manager and author from Seeking Alpha and his research. I m one of his subscribers. Value Digger from Seeking Alpha advised the subscribers to his "Value Investor's Stock Club" research to buy CPH at CAD$0.80 per share in 2021:

Value Digger from Seeking Alpha And His Research

 
CPH currently is at about CAD$3.40, while many other stocks including healthcare stocks  have dropped a lot since 2021.

So CPH is an outperformer that has yielded approximately 300% since his BUY recommendation. Enough said. 


 
<< Previous
Bullboard Posts
Next >>